Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Rees

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2024
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelinesRaquel Dávila Fajardo, Giovanni Scarzello, Mark N Gaze, et al.
The Lancet. Respiratory Medicine|July 6, 2025
Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trialsRichard G White, Gavin J Churchyard, Katherine C Horton, et al.
Science (New York, N.Y.)|March 10, 2022
End COVID-19 in low- and middle-income countriesAhmed Mushfiq Mobarak, Edward Miguel, Jason Abaluck, et al.
Journal of Pediatric Surgery|April 29, 2026
Surgical nodal staging in rhabdomyosarcoma of the bladder and/or prostate with or without nodal or metastatic spread. A report from the European paediatric Soft-tissue sarcoma Study Group (EpSSG)Naima Smeulders, Mark N Gaze, Florent Guérin, et al.
Cancers|March 13, 2024
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Cancers|October 16, 2024
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). <i>Cancers</i> 2024, <i>16</i>, 998Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Plos Medicine|January 23, 2015
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisCharles S Morrison, Pai-Lien Chen, Cynthia Kwok, et al.
Plos One|May 1, 2009
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners studyJairam R Lingappa, Erin Kahle, Nelly Mugo, et al.
Lancet (London, England)|February 16, 2010
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trialJairam R Lingappa, Jared M Baeten, Anna Wald, et al.
Frontiers in Immunology|October 2, 2025
No evidence of MMR induced trained immunity to prevent SARS COV2: results from a multi-centre RCTSinead Delany-Moretlwe, Hakim-Moulay Dehbi, Izukanji Sikazwe, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2024
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelinesRaquel Dávila Fajardo, Giovanni Scarzello, Mark N Gaze, et al.
The Lancet. Respiratory Medicine|July 6, 2025
Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trialsRichard G White, Gavin J Churchyard, Katherine C Horton, et al.
Science (New York, N.Y.)|March 10, 2022
End COVID-19 in low- and middle-income countriesAhmed Mushfiq Mobarak, Edward Miguel, Jason Abaluck, et al.
Journal of Pediatric Surgery|April 29, 2026
Surgical nodal staging in rhabdomyosarcoma of the bladder and/or prostate with or without nodal or metastatic spread. A report from the European paediatric Soft-tissue sarcoma Study Group (EpSSG)Naima Smeulders, Mark N Gaze, Florent Guérin, et al.
Cancers|March 13, 2024
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Cancers|October 16, 2024
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). <i>Cancers</i> 2024, <i>16</i>, 998Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Plos Medicine|January 23, 2015
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisCharles S Morrison, Pai-Lien Chen, Cynthia Kwok, et al.
Plos One|May 1, 2009
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners studyJairam R Lingappa, Erin Kahle, Nelly Mugo, et al.
Lancet (London, England)|February 16, 2010
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trialJairam R Lingappa, Jared M Baeten, Anna Wald, et al.
Frontiers in Immunology|October 2, 2025
No evidence of MMR induced trained immunity to prevent SARS COV2: results from a multi-centre RCTSinead Delany-Moretlwe, Hakim-Moulay Dehbi, Izukanji Sikazwe, et al.
Pageof 20